Tags |
|
|
Links |
|
|
Digg It - Medical Billing - GU0 Record Fields 1 Through 7
In the world of medical billing, there is no CMN more dreaded by billers than the DMEPOS CMN. This grandaddy of all CMNs is over 70 fi
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
elds long. You practically need to be a certified medical practitioner to understand it to begin with. In the following series of art
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
icles, we're going to cover the various fields of this monster of a CMN. If there is something you're not clear on, consult your manua
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
l or call your carrier for complete instructions on how to fill out the field in question. So, if you're ready, hang onto your brain c
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ells because you are going to need them for what's to follow.
First of all, it is important to know what DMEPOS stands for. It is an
First of all, it is important to know what DMEPOS stands for. It is an
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
acronym for Durable Medical Equipment, Prosthetics, Orthotics and Supplies. In other words, this CMN covers just about everything unde
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
r the sun related to those three categories. That is the reason why this CMN is so long. It needs to be able to handle a number of it
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ems. We'll begin with field number 1.
GU0 field 1, positions 1 - 3, is the record type. This must be filled with GU0 and most come a
GU0 field 1, positions 1 - 3, is the record type. This must be filled with GU0 and most come a
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
fter all F records for this patient in the claim file. Also, if other CMNs are being transmitted, it must come after all CMNs from GA0
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
to GP0.
GU0 field 2, positions 4 - 5, is the sequence number. This is the number of the CMN in the claim file. There can be up to 9
GU0 field 2, positions 4 - 5, is the sequence number. This is the number of the CMN in the claim file. There can be up to 9
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
9 CMNs transmitted with a claim file. So each record would be GU0-01, GU0-02 and so on.
GU0 field 3, positions 6 - 22, is the patient
GU0 field 3, positions 6 - 22, is the patient
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
control number. This field must contain the same patient ID number that is transmitted in the CA0 record and all subsequent records t
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
hat also transmit this information.
GU0 field 4, position 23, is the cert type. This field tells the carrier if the CMN is an initial
GU0 field 4, position 23, is the cert type. This field tells the carrier if the CMN is an initial
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
, designated with a 1, a recert, designated with a 3, or a revised, which is designated with a 2. One of those codes must be entered.
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
The field cannot be left blank.
GU0 field 5, positions 24 - 25, is the place of service. This field tells the carrier where the actu
GU0 field 5, positions 24 - 25, is the place of service. This field tells the carrier where the actu
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
al service is performed. This must match the info transmitted in the FA0 record field number 7.
GU0 field 6, position 26, is the repl
GU0 field 6, position 26, is the repl
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
acement item field. This field tells the carrier if the item this CMN is for is a replacement item or not. If it is, a Y is entered.
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
Otherwise, you enter an N. This must be entered for all CMNs except DMERC 8.02. For that CMN, this field must be blank.
GU0 field 7
GU0 field 7
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
, positions 27 - 31, is the HCPCS procedure code. This field tells the carrier what the procedure code is for the item this CMN is pre
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
scribing.
In our next installment of medical billing, we'll continue with our review of the GU0 record, picking up with field number 8
In our next installment of medical billing, we'll continue with our review of the GU0 record, picking up with field number 8
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/2267/diggit-Medical-Billing--GU0-Record-Fields-1-Through-7.html">Medical Billing - GU0 Record Fields 1 Through 7</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/2267/diggit-Medical-Billing--GU0-Record-Fields-1-Through-7.html]Medical Billing - GU0 Record Fields 1 Through 7[/url]
Related Articles:
Setting Up A Corporation In Idaho
Medical Billing - Hiring A Staff
Bookmark it:
|